Londinia Opportunities Analyses - 03/20/2025 (GMT) KYMERA THERAPEUTICS INC. - 1H
- U.S. Stocks
- Timeframe : 1H
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Additional analysis
Quotes
KYMERA THERAPEUTICS INC. rating 34.26 USD. On the day, this instrument gained +1.15% with the lowest point at 33.50 USD and the highest point at 34.71 USD. The deviation from the price is +2.27% for the low point and -1.30% for the high point.The Central Gaps scanner detects a bearish opening. A small advantage for sellers in the very short term.
Bearish opening
Type : Bearish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by KYMERA THERAPEUTICS INC.:
Technical
Technical analysis of KYMERA THERAPEUTICS INC. in 1H shows a strongly overall bullish trend. The signals given by the moving averages are 92.86% bullish. This strong bullish trend is confirmed by the strong signals currently being given by short-term moving averages. The Central Indicators market scanner is currently detecting several bullish signals that could impact this trend:
Bullish trend reversal : Moving Average 20
Type : Bullish
Timeframe : 1 hour
Bullish trend reversal : Moving Average 100
Type : Bullish
Timeframe : 1 hour
The probability of a further increase is high given the direction of the technical indicators.
Caution: the Central Indicators scanner currently detects an excess:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
MACD crosses UP its Moving Average
Type : Bullish
Timeframe : 1 hour
Price is back over the pivot point (Daily)
Type : Bullish
Timeframe : 1 hour
Price is back over the pivot point (Weekly)
Type : Bullish
Timeframe : 1 hour
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
The presence of a bullish Japanese candlestick pattern detected by Central Candlesticks that could cause a very short term rebound was also detected:
Bullish engulfing lines
Type : Bullish
Timeframe : 1 hour
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 29.85 | 31.99 | 33.57 | 34.26 | 34.98 | 36.68 | 37.85 |
Change (%) | -12.87% | -6.63% | -2.01% | - | +2.10% | +7.06% | +10.48% |
Change | -4.41 | -2.27 | -0.69 | - | +0.72 | +2.42 | +3.59 |
Level | Major | Major | Major | - | Intermediate | Minor | Minor |
Attention could also be paid to pivot points to set price objectives:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 30.83 | 31.79 | 32.83 | 33.79 | 34.83 | 35.79 | 36.83 |
Camarilla | 33.32 | 33.50 | 33.69 | 33.87 | 34.05 | 34.24 | 34.42 |
Woodie | 30.87 | 31.81 | 32.87 | 33.81 | 34.87 | 35.81 | 36.87 |
Fibonacci | 31.79 | 32.55 | 33.03 | 33.79 | 34.55 | 35.03 | 35.79 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 28.13 | 29.84 | 32.10 | 33.81 | 36.07 | 37.78 | 40.04 |
Camarilla | 33.28 | 33.64 | 34.01 | 34.37 | 34.73 | 35.10 | 35.46 |
Woodie | 28.42 | 29.98 | 32.39 | 33.95 | 36.36 | 37.92 | 40.33 |
Fibonacci | 29.84 | 31.35 | 32.29 | 33.81 | 35.32 | 36.26 | 37.78 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 16.33 | 22.74 | 27.05 | 33.46 | 37.77 | 44.18 | 48.49 |
Camarilla | 28.40 | 29.39 | 30.37 | 31.35 | 32.33 | 33.32 | 34.30 |
Woodie | 15.27 | 22.22 | 25.99 | 32.94 | 36.71 | 43.66 | 47.43 |
Fibonacci | 22.74 | 26.84 | 29.37 | 33.46 | 37.56 | 40.09 | 44.18 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
RSI (14): | 56.38 | |
MACD (12,26,9): | 0.0100 | |
Directional Movement: | 8.22 | |
AROON (14): | -28.57 | |
DEMA (21): | 33.92 | |
Parabolic SAR (0,02-0,02-0,2): | 32.79 | |
Elder Ray (13): | 0.46 | |
Super Trend (3,10): | 32.77 | |
Zig ZAG (10): | 34.39 | |
VORTEX (21): | 1.0500 | |
Stochastique (14,3,5): | 68.50 | |
TEMA (21): | 33.80 | |
Williams %R (14): | -17.75 | |
Chande Momentum Oscillator (20): | 0.32 | |
Repulse (5,40,3): | 1.6900 | |
ROCnROLL: | 1 | |
TRIX (15,9): | -0.0200 | |
Courbe Coppock: | 0.77 |
MA7: | 34.21 | |
MA20: | 33.39 | |
MA50: | 37.01 | |
MA100: | 40.92 | |
MAexp7: | 33.89 | |
MAexp20: | 33.91 | |
MAexp50: | 33.72 | |
MAexp100: | 33.71 | |
Price / MA7: | +0.15% | |
Price / MA20: | +2.61% | |
Price / MA50: | -7.43% | |
Price / MA100: | -16.28% | |
Price / MAexp7: | +1.09% | |
Price / MAexp20: | +1.03% | |
Price / MAexp50: | +1.60% | |
Price / MAexp100: | +1.63% |
News
Don't forget to follow the news on KYMERA THERAPEUTICS INC.. At the time of publication of this analysis, the latest news was as follows:
- Kymera Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
- Kymera Therapeutics to Participate in Upcoming March Investor Conferences
- Kymera Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27
- Kymera Therapeutics to Participate in Upcoming February Investor Conferences
- Kymera Therapeutics Outlines Key 2025 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs